Exploring NNMT: from metabolic pathways to therapeutic targets
Park J, Shin EJ, Kim TH, Yang JH, Ki SH, Kang KW, Kim KM
- Archives of Pharmacal Research (2024) 47(12):893-913 (IF: 6.9, JCR 4.2%) (Review)
Kim DH, Kim J, Park J, Kim TH, Han YH
- Life Sciences (2024) 356:123042 (IF: 5.2, JCR 11.3%)
Epsti1 Regulates the Inflammatory Stage of Early Muscle Regeneration through STAT1-VCP Interaction.
Kim JW, Bae JH, Go GY, Lee JR, Jeong Y, Kim JY, Kim TH, Kim YK, Han JW, Oh JE, Hahn MJ, Kang JS, Bae GU
- International Journal of Biological Sciences (2024) 20(9): 3530-3543 (IF: 8.2, JCR 9.9%)
Fortibui MM$, Park C$, Kim NY, Kim TH*, Lee MH*
- Analytical Chemistry (2024) 96: 9408-9415 (IF: 6.7, JCR 5.7%) ($equally contributed; *co-correspondence)
Kim TH
- Journal of Ginseng Research (2024) 48(3): 276-285 (IF: 6.8, JCR 2.3%) (Review)
Park S, Hwang S, Sun J, Jeon KH, Sheen N, Shin S, Kim TH, Lee YS, Seo W, Ryu JS, Kwon Y.
- International Journal of Biological Sciences (2024) 20(5): 1855-1870 (IF: 8.2, JCR 9.9%)
Ginsenoside Rg5 promotes muscle regeneration via p38MAPK and Akt/mTOR signaling.
Kim R, Kim JW, Choi H, Oh JE, Kim TH, Go GY, Lee SJ, Bae GU.
- Journal of Ginseng Research (2023) 47:726-734 (IF: 6.8, JCR 2.3%)
Targeting liver X receptors for the treatment of non-alcoholic fatty liver disease.
Kim H, Park C, Kim TH.
- Cells (2023) 12(9): 1292 (IF: 5.1, JCR 30.7%) (Review)
Ha Y*, Jeong I*, Kim TH.
- Biomedicines (2022) 10:2530. (IF: 3.9, JCR 24.0%) (Review) (*equally contributed)
Tak J, Kim YS, Kim TH, Park GC, Hwang S, Kim SG.
- Theranostics (2022) 12(4):1570-1588. (IF: 12.4, JCR 4.2%)
NRF2-mediated SIRT3 induction protects hepatocytes from ER stress-induced liver injury.
Kim A, Koo JH, Lee JM, Joo MS, Kim TH, Kim H, Jun DW, Kim SG.
- FASEB J (2022) 36(3):e22170. (IF: 4.4, JCR 13.8%)
Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism.
Kim TH, Hong DG, Yang YM.
- Biomedicines (2021) 9:1903. (IF: 3.9, JCR 24.0%) (Review)
Kim TH, Koo JH, Heo MJ, Han CY, Kim YI, Park SY, Cho IJ, Lee CH, Choi CS, Lee JW, Kim W, Cho JY, Kim SG.
- Science Translational Medicine (2019) 11(513):eann4735. (IF: 15.8, JCR 1.1%)
Wu HM, Kim TH, Kim A, Koo JH, Joo MS, Kim SG.
- Hepatology Communications (2019) 3(10):1373-1387. (IF: 5.6, JCR 16.8%)
Role of CXCR6 in Antitumor Immune Surveillance.
Kim TH, Kim SG.
- Gastroenterology (2019) 156(6):1565-1568. (IF: 25.7, JCR 2.8%) (Editorial)
Joo MS, Koo JH, Kim TH, Kim YS, Kim SG.
- EbioMedicine (2019) 40:488-503. (IF: 9.7, JCR 6.4%)
Heo MJ, Kim TH, You JS, Blaya D, Sancho-Bru P, Kim SG.
- Gut (2019) 68:704-720. (IF: 23.0, JCR 3.5%)
Kim TH*, Yang YM*, Han CY, Koo JH, Oh H, Kim SS, You BH, Choi YH, Park TS, Lee CH, Kurose H, Noureddin M, Seki E, Wan YY, Choi CS, Kim SG.
- Journal of Clinical Investigation (2018) 128(12):5587-5602. (IF: 13.3, JCR 2.1%) (*equal contribution)
Han CY, Rho HS, Kim A, Kim TH, Jang K, Jun DW, Kim JW, Kim B, Kim SG.
- Cell Reports (2018) 24(11):2985-2999. (IF: 8.8, JCR 17.6%)
Gα13 ablation reprograms myofibers to oxidative phenotype and enhances whole-body metabolism.
Koo JH, Kim TH, Park SY, Joo MS, Han CY, Choi CS, Kim SG.
- Journal of Clinical Investigation (2017) 127(10):3845-3860. (IF: 13.3, JCR 2.1%)
Farnesoid X receptor as a regulator of fuel consumption and mitochondrial function.
Han CY*, Kim TH*, Koo JH, Kim SG.
- Archives of Pharmacal Research (2016) 39(8):1062-1074. (IF: 6.9, JCR 4.2%) (*equal contribution)
Yang YM, Lee CG, Koo JH, Kim TH, Lee JM, An J, Kim KM, Kim SG.
- Oncotarget (2015) 6(22):19055-19069.
Shin SY*, Kim TH*, Wu H, Choi YH, Kim SG.
- European Journal of Pharmacology (2014) 727:115-124. (IF: 4.2, JCR 11.3%) (*equal contribution)
Kim TH, Eom JS, Lee CG, Yang YM, Lee YS, Kim SG.
- British Journal of Pharmacology (2013) 168(7):1647-1161. (IF: 6.8, JCR 5.1%)
Yang YM, Seo SY, Kim TH, Kim SG.
- Hepatology (2012) 56(6):2209-2220. (IF: 12.9, JCR 4.9%)
Kim TH, Kim SG.
- Safety and Health at Work (2011) 2(2):97-104. (IF: 3.5, JCR 20.8%) (Review)
Kim YM*, Kim TH*, Kim YW, Yang YM, Ryu da H, Hwang SJ, Lee JR, Kim SC, Kim SG.
- Free Radical Biology and Medicine (2010) 49(11):1722-1734. (IF: 7.1, JCR 8.1%) (*equal contribution)
Kay HY, Won Yang J, Kim TH, Lee da Y, Kang B, Ryu JH, Jeon R, Kim SG.
- Journal of Nutrition (2010) 140:1211-1219. (IF: 3.7, JCR 32.5%)
Kim TH, Kim YW, Shin SM, Kim CW, Yu IJ, Kim SG.
- Chemico-Biological Interactions (2010) 184(3):492-501. (IF: 4.7, JCR 15.1%)
Kim YW, Kim YM, Yang YM, Kim TH, Hwang SJ, Lee JR, Kim SC, Kim SG.
- Free Radical Biology and Medicine (2010) 48(4):567-578. (IF: 7.1, JCR 8.1%)